When unexpected complications raise concerns for you or your fetus, our Maternal-Fetal Medicine physicians offer specialized treatment and testing. Whether you need a procedure to help prevent premature delivery or testing for possible genetic disorders, North Florida Perinatal Associates offers the expert care you need, when you need it most.
These procedures are two of the most reliable ways to assess the genetic well-being of fetuses.
CVS involves obtaining DNA from a tiny tissue sample of the placenta and is usually performed between 11 and 14 weeks of pregnancy.
Amniocentesis acquires genetic information from a sample of the amniotic fluid and is usually performed after 15 weeks of pregnancy, by obtaining a sample of the amniotic fluid around the fetus using ultrasound guidance.
Either procedure can be suggested:
Both procedures have proven to be safe and reliable for decades. However, there is a small risk for complications. Before you have a CVS or amniocentesis, we will meet with you to discuss the risks and benefits and help you make the best choice for you and your fetus.
Although a targeted fetal ultrasound is not a 3-D ultrasound, the images it generates are highly detailed.
Fetal well-being assessment can help identify any medical conditions that might threaten a normal outcome. Fetal well-being is determined in several ways, the simplest is the mother's own perception of her fetus's movement. The following indicators help your physician determine your fetus's well-being:
These assessments are typically taken weekly but your physician may recommend more frequent testing as needed.